Elevance Health (ELV) reported Q4 adjusted earnings Thursday of $3.84 per diluted share, down from $5.62 a year earlier.

Analysts surveyed by FactSet expected $3.81.

Total revenue for the quarter ended Dec. 31 was $45.44 billion, compared with $42.65 billion a year earlier.

Analysts surveyed by FactSet expected $44.92 billion.

For 2025, the company said it expects adjusted diluted EPS in the range of $34.15 to $34.85. A single analyst polled by FactSet expects $34.52.

Shares were up more than 4% in premarket activity.